Funding opp: Boehringer Ingelheim accepting proposals for investigator-initiated studies.

Pharmaceutical company Boehringer Ingelheim is currently accepting proposals for investigator-initiated studies in the following areas:

• Respiratory - COPD
• Cardiovascular - Stroke Prevention in Atrial Fibrillation
• Oncology - Solid Tumors
• Endocrinology - Diabetes

While the research interests listed within the therapeutic areas are of focus to BIPI, other novel research interests may be considered. Learn more here.